Beyond Complete Revascularization in STEMI: Revisiting the Vulnerable Plaque Hypothesis and the Emerging Role of Preventive PCI in Non-Culprit Coronary Arteries.
文献摘要
Complete revascularization is the preferred treatment strategy for hemodynamically stable patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease. However, substantial residual cardiovascular risk persists despite successful treatment of angiographically or physiologically significant lesions, highlighting the limitations of revascularization strategies based solely on stenosis severity or ischemia. Increasing evidence demonstrates that many subsequent acute coronary syndromes originate from biologically high-risk, non-flow-limiting non-culprit plaques rather than flow-limiting lesions. In this review, we discuss the evolution of STEMI management from the recent focus on complete revascularization toward plaque-guided strategies, including the role of invasive and non-invasive imaging for vulnerable plaque assessment, the emerging evidence supporting preventive PCI of high-risk non-culprit lesions, and ongoing clinical trials shaping this field. Collectively, these advances provide a framework for investigating precision revascularization strategies that integrate plaque morphology, coronary physiology, multimodality imaging, and patient-level cardiovascular risk. Ongoing randomized trials are essential to determine whether plaque-guided preventive intervention improves clinically meaningful outcomes beyond contemporary approaches to revascularization and optimal medical therapy.